Results from OVATION 2 Study continue to validate TheraPlas® technology, demonstrating DNA-mediated production of key anti-cancer immune cytokines following treatment IMNN-001 continues to show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback